Lupin and Axantia enter into license-, supply- and technology-sharing agreement for Pegfilgrastim EP News Bureau Feb 2, 2022 Under the terms of the agreement, Axantia will register, distribute and market biosimilar Pegfilgrastim drug product in certain…
